$5.09
-0.11-2.12%
At Close: -
$5.19
0.11.96%
After Hours: 5:30 PM EDT
15 minutes delayed
Aquestive Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Aquestive Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $-0.03 | $-0.12 | 75.0 % |
Mar 2024 | 2024-05-07 | $-0.17 | $-0.08 | -112.5 % |
Dec 2023 | 2024-03-05 | $-0.10 | $-0.08 | -25.0 % |
Sep 2023 | 2023-11-06 | $-0.03 | $-0.11 | 72.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $20.10M | $12.38M | 62.4 % |
Mar 2024 | 2024-05-07 | $12.05M | $12.26M | -1.69 % |
Dec 2023 | 2024-03-05 | $13.21M | $11.63M | 13.6 % |
Sep 2023 | 2023-11-06 | $13.00M | $11.51M | 13.0 % |
Aquestive Therapeutics (AQST) is scheduled to report earnings on November 4, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
The Actual EPS was $-0.03, which beat the estimate of $-0.12.
The Actual Revenue was $20.1M, which beat the estimate of $12.4M.
Browse earnings estimates, EPS, and revenue on all stocks.